bicalutamide has been researched along with abarelix in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barzell, W; Campion, M; Fotheringham, N; Friedel, W; Garnick, MB; Gittleman, M; Pessis, D; Steidle, C; Trachtenberg, J | 1 |
Bhat, G; Bubley, GJ; Garnick, MB; Manola, J; Yannucci, J | 1 |
1 trial(s) available for bicalutamide and abarelix
Article | Year |
---|---|
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Humans; Leuprolide; Male; Middle Aged; Nitriles; Oligopeptides; Prostatic Neoplasms; Tosyl Compounds | 2002 |
1 other study(ies) available for bicalutamide and abarelix
Article | Year |
---|---|
The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Blood Glucose; Cholesterol; Fasting; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Nitriles; Oligopeptides; Prostatic Neoplasms; Tosyl Compounds | 2006 |